TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,374 | -1.5% | 412 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,473 | -4.7% | 412 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,790 | +306.8% | 412 | +285.0% | 0.00% | – |
| Q4 2022 | $1,669 | +66.9% | 107 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 107 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 107 | -74.6% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | +500.0% | 421 | +453.9% | 0.00% | – |
| Q4 2021 | $1,000 | -85.7% | 76 | -80.9% | 0.00% | -100.0% |
| Q3 2021 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $7,000 | 0.0% | 398 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 398 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -14.3% | 398 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $7,000 | – | 398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |